[Federal Register Volume 86, Number 184 (Monday, September 27, 2021)]
[Notices]
[Pages 53316-53317]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20920]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Solicitation of Nominations for Appointment to the Interagency 
Committee on Smoking and Health (ICSH)

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) is 
seeking nominations for membership on the ICSH. The ICSH consists of 
five public members, as deemed by statute, that represent private 
entities involved in informing the public about the health effects of 
smoking.

DATES: Nominations for membership on the ICSH must be received no later 
than October 22, 2021. Packages received after this time will not be 
considered for the current membership cycle.

ADDRESSES: All nominations should be emailed to Jade Chambers Blair, 
Office on Smoking and Health, National Center for Chronic Disease 
Prevention and Health Promotion (NCCDPHP), CDC, to 
[email protected].

FOR FURTHER INFORMATION CONTACT: Kathy Gallagher, Designated Federal 
Official, ICSH, Office on Smoking and Health, NCCDPHP, CDC, 1600 
Clifton Road NE, Atlanta, Georgia 30329-4027, Telephone: (404) 639-
6358, or email at [email protected].

SUPPLEMENTARY INFORMATION: Nominations are being sought for individuals 
who have expertise and qualifications necessary to contribute to the 
accomplishments of the committee's objectives. Nominees will be 
selected based on expertise in the fields of the health effects of 
smoking. Additionally, desirable qualifications include: (1) Knowledge 
of evidence based and emerging commercial tobacco control policies as 
well as experience in analyzing, evaluating, and interpreting Federal, 
State and/or local health or regulatory policy; and/or (2) familiarity 
and expertise in developing or contributing to the development of 
policies and/or programs to advance health equity by identifying and 
eliminating commercial tobacco product related inequities and 
disparities; (3) knowledge of the intersection of behavioral health 
conditions (mental health and/or substance use disorders) and 
commercial tobacco use/tobacco control and/or (4) familiarity and 
expertise with the treatment of commercial tobacco use and dependence, 
particularly with respect to developing or contributing to 
interventions for reducing tobacco-related disparities and inequities 
in the United States. Federal employees will not be considered for 
membership. Members may be invited to serve for four-year terms.
    Selection of members is based on candidates' qualifications to 
contribute to the accomplishment of ICSH objectives https://www.cdc.gov/tobacco/about/icsh/index.htm.
    The U.S. Department of Health and Human Services policy stipulates 
that committee membership be balanced in terms of points of view 
represented, and the committee's function. Appointments shall be made 
without discrimination on the basis of age, race, ethnicity, gender, 
sexual orientation, gender identity, HIV status, disability, and 
cultural, religious, or socioeconomic status. Nominees must be U.S. 
citizens,

[[Page 53317]]

and cannot be full-time employees of the U.S. Government. Current 
participation on federal workgroups or prior experience serving on a 
federal advisory committee does not disqualify a candidate; however, 
HHS policy is to avoid excessive individual service on advisory 
committees and multiple committee memberships. Committee members are 
Special Government Employees, requiring the filing of financial 
disclosure reports at the beginning and annually during their terms. 
CDC reviews potential candidates for ICSH membership each year and 
provides a slate of nominees for consideration to the Secretary of HHS 
for final selection. HHS notifies selected candidates of their 
appointment near the start of the term in July 2022, or as soon as the 
HHS selection process is completed. Note that the need for different 
expertise varies from year to year and a candidate who is not selected 
in one year may be reconsidered in a subsequent year.
    Candidates should submit the following items:
    [ssquf] Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, email address).
    [ssquf] At least one letter of recommendation from person(s) not 
employed by the U.S. Department of Health and Human Services. 
(Candidates may submit letter(s) from current HHS employees if they 
wish, but at least one letter must be submitted by a person not 
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
    Nominations may be submitted by the candidate him- or herself, or 
by the person/organization recommending the candidate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-20920 Filed 9-24-21; 8:45 am]
BILLING CODE 4163-18-P